Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Anti-acne Cosmetics Market, by Product
1.4.2 North America Anti-acne Cosmetics Market, by End Use
1.4.3 North America Anti-acne Cosmetics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Anti-acne Cosmetics Market by Product
3.1 North America Creams & Lotions Market by Country
3.2 North America Cleanser & Toner Market by Country
3.3 North America Mask Market by Country
3.4 North America Other Products Market by Country
Chapter 4. North America Anti-acne Cosmetics Market by End Use
4.1 North America Women Market by Country
4.2 North America Men Market by Country
Chapter 5. North America Anti-acne Cosmetics Market by Country
5.1 US Anti-acne Cosmetics Market
5.1.1 US Anti-acne Cosmetics Market by Product
5.1.2 US Anti-acne Cosmetics Market by End Use
5.2 Canada Anti-acne Cosmetics Market
5.2.1 Canada Anti-acne Cosmetics Market by Product
5.2.2 Canada Anti-acne Cosmetics Market by End Use
5.3 Mexico Anti-acne Cosmetics Market
5.3.1 Mexico Anti-acne Cosmetics Market by Product
5.3.2 Mexico Anti-acne Cosmetics Market by End Use
5.4 Rest of North America Anti-acne Cosmetics Market
5.4.1 Rest of North America Anti-acne Cosmetics Market by Product
5.4.2 Rest of North America Anti-acne Cosmetics Market by End Use
Chapter 6. Company Profiles
6.1 Estee Lauder Companies, Inc. (Clinique)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.2 Unilever PLC (Murad Skincare)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Johnson and Johnson
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental &Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 L'Oreal Group
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Acquisition and Mergers:
6.4.5.2 Product Launches and Product Expansions:
6.5 LVMH SE
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Beiersdorf AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 KOSE Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.8 Rohto Pharmaceutical Co., Ltd. (Mentholatum)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research and Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Product Launches and Product Expansions:
6.9 The Proactiv Company LLC (Guthy-Renker LLC)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Product Launches and Product Expansions:
6.9.2.2 Partnerships, Collaborations, and Agreements:
6.10. Ancalima Lifesciences Limited
6.10.1 Company Overview
Unique Offerings 